Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Brain Research
|
August 29, 1994
Dopamine release in the rat cerebellum and hippocampus: a tissue 3-methoxytyramine study
S J Chrapusta, M F Egan, J M Masserano, et al.
Brain Research
|
August 5, 1998
Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia
E H Hamid, T M Hyde, S M Baca, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 1, 1993
Serum creatine phosphokinase elevations in patients with tardive dyskinesia
M F Egan, A A Dargham, D G Kirch, et al.
Schizophrenia Research
|
January 1, 1988
Schizophrenia, just the facts. What do we know, how well do we know it?
R J Wyatt, R C Alexander, M F Egan, et al.
Biological Psychiatry
|
September 22, 2001
Event-related potentials and genetic risk for schizophrenia
G Winterer, M F Egan, T Rädler, et al.
Biological Psychiatry
|
November 1, 1994
Effects of chronic cocaine treatment on rat brain: long-term reduction in frontal cortical serotonin
M F Egan, L Wing, R Li, et al.
Psychological Medicine
|
May 25, 2002
Effects of neuroleptic medications on speech disorganization in schizophrenia: biasing associative networks towards meaning
T E Goldberg, M Dodge, M Aloia, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1996
Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine
M F Egan, S Chrapusta, F Karoum, et al.
Schizophrenia Research
|
May 10, 2001
An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia
G Winterer, M F Egan, T Rädler, et al.
Biological Psychiatry
|
June 1, 1992
Laterality of appendicular tardive dyskinesia in chronic schizophrenia
M F Egan, T M Hyde, D L Tirschwell, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Brain Research
|
August 29, 1994
Dopamine release in the rat cerebellum and hippocampus: a tissue 3-methoxytyramine study
S J Chrapusta, M F Egan, J M Masserano, et al.
Brain Research
|
August 5, 1998
Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia
E H Hamid, T M Hyde, S M Baca, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 1, 1993
Serum creatine phosphokinase elevations in patients with tardive dyskinesia
M F Egan, A A Dargham, D G Kirch, et al.
Schizophrenia Research
|
January 1, 1988
Schizophrenia, just the facts. What do we know, how well do we know it?
R J Wyatt, R C Alexander, M F Egan, et al.
Biological Psychiatry
|
September 22, 2001
Event-related potentials and genetic risk for schizophrenia
G Winterer, M F Egan, T Rädler, et al.
Biological Psychiatry
|
November 1, 1994
Effects of chronic cocaine treatment on rat brain: long-term reduction in frontal cortical serotonin
M F Egan, L Wing, R Li, et al.
Psychological Medicine
|
May 25, 2002
Effects of neuroleptic medications on speech disorganization in schizophrenia: biasing associative networks towards meaning
T E Goldberg, M Dodge, M Aloia, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1996
Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine
M F Egan, S Chrapusta, F Karoum, et al.
Schizophrenia Research
|
May 10, 2001
An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia
G Winterer, M F Egan, T Rädler, et al.
Biological Psychiatry
|
June 1, 1992
Laterality of appendicular tardive dyskinesia in chronic schizophrenia
M F Egan, T M Hyde, D L Tirschwell, et al.
Page
of 7